Post has attachment
Dr. Pasi Jänne and his team from the Dana-Farber Cancer Institute are studying novel approaches to targeting KRAS mutations in lung cancer, through a Stand Up To Cancer grant. Read more in the LUNGevity Experts Blog:

Post has attachment
LUNGevity Career Development awardee Dr. Timothy Burns is studying how we can target the KRAS gene mutation, which occurs in 25% of adenocarcinoma patients. Read more in the LUNGevity Experts Blog:

Post has attachment
Check out the Spring edition of LUNGevity's Fresh Air newsletter for the latest news on scientific progress and ways to join the lung cancer movement! https://www.lungevity.org/sites/default/files/general/media-resources/newsletter-spring-2017.pdf
Photo

Post has attachment
LUNGevity's newest Scientific Advisory Board member Alice Shaw, MD, PhD, of Massachusetts General Hospital/Harvard Medical School is an internationally recognized expert on driver mutations―mutations that promote the growth of cancer cells in non-small cell lung cancer. Dr. Shaw brings expertise in targeted therapies and other key areas to LUNGevity’s research program. Read the full press release:

Post has attachment
Patient FoRCe, LUNGevity’s Patient-Focused Research Center, will undertake never-before studies of those living with lung cancer, collecting and sharing robust qualitative and quantitative data about lung cancer patients’ preferences and experiences to inform treatment, as well as relevant policy and research protocols. Read more:

Post has attachment
Dr. Lecia Sequist, a leader in the field of targeted therapeutics and member of LUNGevity’s SAB, is conducting cutting-edge research to develop more treatment options for her patients. She is also a dedicated mentor, committed to training the new generation of doctors and researchers. Read more about Dr. Sequist's research in the latest LUNGevity Experts Blog:

Post has attachment
LUNGevity Scientific Advisory Board member Dr. Suzanne Dahlberg is an integral member of major lung cancer clinical trial teams. Read more about how she ensures that trials are set up correctly and that results are interpreted accurately in the latest Experts blog: https://www.lungevity.org/about-lung-cancer/experts-blog/dr-suzanne-dahlberg-talks-biostatistics-how-to-ensure-strong-science
Photo

Post has attachment
The field of targeted therapies is exploding like never before. LUNGevity Scientific Advisory Board members and awardees are integral drivers of this progress.

Post has attachment
Thank you to the Baltimore Orioles for raising awareness about lung cancer and LUNGevity in memory of Monica Barlow, their former Director of Public Relations who passed away from lung cancer in February 2014. Monica was a strong advocate for lung cancer research. The Breathe Deep Baltimore walk in honor of Monica will be held on Saturday, September 16, at Oriole Park in Camden Yards.

Post has attachment
LUNGevity Foundation is excited to announce that country music star Wade Hayes will be sharing his cancer journey with lung cancer survivors and their caregivers at the 7th Annual National HOPE Summit on April 29 in Washington, DC. As opening keynote speaker, he will relate his experiences before the largest convening of lung cancer survivors in the country. Read the full press release:
Wait while more posts are being loaded